JPRN-jRCT2080224119已完成3 期
A phase 3 randomized, double-blind, placebo-controlled study to confirm the efficacy of a single dose of baloxavir marboxil in the prevention of influenza virus infection
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 752
研究概览
简要总结
The efficacy of baloxavir marboxil was demonstrated compared with placebo in the prevention of influenza virus infection in subjects who were household members of influenza-infected patients. A single oral dose of baloxavir marboxil for the prevention of influenza virus infection was well tolerated.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Subjects who had lived with the patients with influenza virus infection for 48 hours or more prior to informed consent.
- •-Subjects who are judged not to have influenza virus infection by the investigator.
排除标准
- •-Subjects who are unable to live with the index patient from Screening until Day 10.
- •-Subjects who have any underlying diseases requiring systemic (oral or injection), or nasal treatment of antipyretics/analgesics, corticosteroids, or immunosuppressive agents.
研究者
相似试验
已完成
3 期
Study to Assess Efficacy and Safety of Baloxavir Marboxil In Combination With Standard-of-Care Neuraminidase Inhibitor In Hospitalized Participants With Severe InfluenzaInfluenzaNCT03684044Hoffmann-La Roche363
已完成
3 期
Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in HouseholdsInfluenzaNCT03969212Hoffmann-La Roche4,138
已完成
3 期
Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Chinese Pediatric Participants 1 to <12 Years of Age With Influenza SymptomsInfluenzaNCT06774859Hoffmann-La Roche100
已完成
3 期
Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants With Influenza-Like SymptomsInfluenzaNCT03629184Hoffmann-La Roche173
进行中（未招募）
3 期
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKEIschemic Stroke Ischemic Attack, TransientNCT05702034Janssen Research & Development, LLC12,523